SLC9A4
Basic information
Region (hg38): 2:102473226-102533972
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC9A4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 46 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 46 | 2 | 1 |
Variants in SLC9A4
This is a list of pathogenic ClinVar variants found in the SLC9A4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-102473800-G-A | not specified | Uncertain significance (Jan 10, 2022) | ||
2-102473809-T-C | Benign (Jun 13, 2018) | |||
2-102473836-C-T | not specified | Uncertain significance (Oct 14, 2023) | ||
2-102473868-A-G | not specified | Uncertain significance (Jul 09, 2021) | ||
2-102473889-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
2-102473916-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
2-102473928-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
2-102473971-A-C | not specified | Uncertain significance (Oct 26, 2022) | ||
2-102474013-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
2-102476054-C-T | Ascending aortic dissection | association (Feb 01, 2021) | ||
2-102478941-A-C | not specified | Uncertain significance (Aug 28, 2021) | ||
2-102478945-G-A | Ascending aortic dissection | association (Feb 01, 2021) | ||
2-102479033-T-C | not specified | Uncertain significance (Jul 12, 2022) | ||
2-102479058-T-G | not specified | Uncertain significance (Jul 05, 2023) | ||
2-102479070-T-C | not specified | Uncertain significance (Mar 25, 2022) | ||
2-102479079-C-A | not specified | Uncertain significance (Mar 31, 2024) | ||
2-102479128-G-C | not specified | Uncertain significance (Oct 25, 2023) | ||
2-102479210-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
2-102479241-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
2-102479258-A-G | not specified | Uncertain significance (Jun 18, 2021) | ||
2-102479286-A-G | not specified | Uncertain significance (Feb 10, 2022) | ||
2-102479289-A-T | not specified | Uncertain significance (Jul 12, 2022) | ||
2-102503455-A-G | not specified | Uncertain significance (May 22, 2024) | ||
2-102503536-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
2-102503541-G-A | not specified | Likely benign (May 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC9A4 | protein_coding | protein_coding | ENST00000295269 | 12 | 60670 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.29e-14 | 0.236 | 125619 | 1 | 128 | 125748 | 0.000513 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.611 | 492 | 455 | 1.08 | 0.0000250 | 5245 |
Missense in Polyphen | 192 | 185.54 | 1.0348 | 2206 | ||
Synonymous | -0.667 | 191 | 180 | 1.06 | 0.0000110 | 1559 |
Loss of Function | 1.12 | 24 | 30.7 | 0.782 | 0.00000155 | 360 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00386 | 0.00386 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000654 | 0.000653 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000317 | 0.000308 |
Middle Eastern | 0.000654 | 0.000653 |
South Asian | 0.000393 | 0.000327 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in pH regulation to eliminate acids generated by active metabolism or to counter adverse environmental conditions. Major proton extruding system driven by the inward sodium ion chemical gradient. Plays an important role in signal transduction. May play a specialized role in the kidney in rectifying cell volume in response to extreme fluctuations of hyperosmolar-stimulated cell shrinkage. Is relatively amiloride and ethylisopropylamiloride (EIPA) insensitive. Can be activated under conditions of hyperosmolar-induced cell shrinkage in a sustained intracellular acidification-dependence manner. Activated by 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) in a sustained intracellular acidification-dependence manner. Affects potassium/proton exchange as well as sodium/proton and lithium/proton exchange. In basolateral cell membrane, participates in homeostatic control of intracellular pH, and may play a role in proton extrusion in order to achieve transepithelial HCO3(-) secretion. In apical cell membrane may be involved in mediating sodium absorption. Requires for normal levels of gastric acid secretion, secretory membrane development, parietal cell maturation and/or differentiation and at least secondarily for chief cell differentiation (By similarity). {ECO:0000250}.;
- Pathway
- Gastric acid secretion - Homo sapiens (human);Beta-agonist/Beta-blocker Pathway, Pharmacodynamics;Sodium/Proton exchangers;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.911
- rvis_EVS
- 0.85
- rvis_percentile_EVS
- 88.49
Haploinsufficiency Scores
- pHI
- 0.140
- hipred
- N
- hipred_score
- 0.231
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.818
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc9a4
- Phenotype
- immune system phenotype; skeleton phenotype; digestive/alimentary phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- gastric acid secretion;epithelial cell development;ion transport;regulation of intracellular pH;potassium ion transmembrane transport;sodium ion import across plasma membrane;proton transmembrane transport
- Cellular component
- plasma membrane;integral component of membrane;basolateral plasma membrane;apical plasma membrane
- Molecular function
- sodium:proton antiporter activity;potassium:proton antiporter activity